DNA double-strand break formation and repair as targets for novel antibiotic combination chemotherapy

scientific article published on 02 September 2019

DNA double-strand break formation and repair as targets for novel antibiotic combination chemotherapy is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.2144/FSOA-2019-0034
P932PMC publication ID6745595
P698PubMed publication ID31534779
P8602University of Ghana Digital Collections (UGSpace) ID32402

P50authorPatrick Kobina ArthurQ55112172
Vincent AmarhQ63494520
P2093author name stringPatrick K Arthur
Vincent Amarh
Amarh, V.
P2860cites workAfter 30 years of study, the bacterial SOS response still surprises usQ21092806
SOS response induces persistence to fluoroquinolones in Escherichia coliQ21144990
New treatment options against gram-negative organismsQ21194906
Biochemistry of homologous recombination in Escherichia coliQ24634614
RecBCD enzyme and the repair of double-stranded DNA breaksQ24650931
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistanceQ27664216
The double-strand-break repair model for recombinationQ28267259
How RecBCD enzyme and Chi promote DNA break repair and recombination: a molecular biologist's viewQ28268622
Rifamycin-mode of action, resistance, and biosynthesisQ28306550
RecA protein: structure, function, and role in recombinational DNA repairQ30427530
An end-joining repair mechanism in Escherichia coliQ33719661
Mode of action of fluoroquinolonesQ33770059
Spontaneous DNA breakage in single living Escherichia coli cellsQ33796363
How antibiotics kill bacteria: from targets to networksQ33958766
Mycobacteria exploit three genetically distinct DNA double-strand break repair pathwaysQ34158258
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.Q34177418
Mechanisms of action of antimicrobials: focus on fluoroquinolonesQ34183520
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. HydeQ34187326
The antibiotic resistance crisis: part 1: causes and threatsQ34471028
Error-Prone Repair of DNA Double-Strand BreaksQ34478858
The natural history of antibioticsQ34986016
Non-homologous end-joining: bacteria join the chromosome breakdanceQ35063174
Something old, something new: revisiting natural products in antibiotic drug discoveryQ35109342
Versatility of aminoglycosides and prospects for their futureQ35176271
Branch migration prevents DNA loss during double-strand break repairQ35221144
Targets for Combating the Evolution of Acquired Antibiotic ResistanceQ35754447
Role of DNA repair by nonhomologous-end joining in Bacillus subtilis spore resistance to extreme dryness, mono- and polychromatic UV, and ionizing radiationQ35759710
Mechanisms of resistance to quinolonesQ36155441
DNA repair and genome maintenance in Bacillus subtilisQ36194928
Mechanisms of drug resistance: quinolone resistanceQ36225422
Global fluoroquinolone resistance epidemiology and implictions for clinical use.Q36337074
Xenobiotics shape the physiology and gene expression of the active human gut microbiomeQ36554412
New antibiotic agents in the pipeline and how they can help overcome microbial resistanceQ36845895
Quinolone-mediated bacterial death.Q36921143
Double-strand break repair in bacteria: a view from Bacillus subtilisQ37868655
Early steps of double-strand break repair in Bacillus subtilis.Q38079073
Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.Q38980013
The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteriaQ39279622
Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli.Q39817311
Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell divisionQ39871693
Mechanism of Action of Nalidixic Acid on Escherichia coli III. Conditions Required for LethalityQ40434882
Two alternative pathways of double-strand break repair that are kinetically separable and independently modulatedQ40678286
The multifaceted roles of antibiotics and antibiotic resistance in natureQ41249257
The bactericidal activity of DR-3355, an optically active isomer of ofloxacinQ44861469
Homologous pairing and DNA strand-exchange proteins.Q45944296
Discovery and Total Synthesis of Natural Cystobactamid Derivatives with Superior Activity against Gram-Negative Pathogens.Q48089588
DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivitiesQ50129292
NHEJ protects mycobacteria in stationary phase against the harmful effects of desiccation.Q50693569
Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.Q52640613
Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyraseQ54308976
SbcCD causes a double-strand break at a DNA palindrome in the Escherichia coli chromosome.Q54425189
Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.Q54773512
Control of crossing overQ64388320
Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16Q67661696
Function of the SOS Process in Repair of DNA Damage Induced by Modern 4-QuinolonesQ72098455
Mechanisms of recombination: lessons from E. coliQ82640171
P433issue8
P921main subjectchemotherapyQ974135
DNA double-strand break repairQ33757109
Microchips for cell-based assays.Q37391418
Problems of antibiotic incompatibility and combination chemotherapyQ66964562
P304page(s)FSO411
P577publication date2019-01-01
2019-09-02
P1433published inFuture science OAQ27726739
P1476titleDNA double-strand break formation and repair as targets for novel antibiotic combination chemotherapy
P478volume5

Search more.